Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Diagnosed With Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03137264
What this trial is testing

Resistance & Activating Mutations Diagnosed Among NSCLC Community Dwelling EGFR Mutation Positive Patients

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 44
Testing effectiveness (Phase 2)Study completedNCT00684567
What this trial is testing

Temozolomide Phase II Clinical Study in Patients With Newly Diagnosed Glioblastoma Multiforme (Study P04661)(COMPLETED)

Who this might be right for
Glioblastoma
Merck Sharp & Dohme LLC 30
Testing effectiveness (Phase 2)Looking for participantsNCT06982274
What this trial is testing

Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia (APL)
Instituto do Cancer do Estado de São Paulo 115
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07731789
What this trial is testing

Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular Lymphoma

Who this might be right for
Classic Follicular LymphomaGrade 1 Follicular LymphomaGrade 2 Follicular Lymphoma+1 more
University of Washington 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07733024
What this trial is testing

Comparing DLL3 PET/CT to Standard Scans in Neuroendocrine Cancer

Who this might be right for
Neuroendocrine Tumors
Tingting Yuan 200
Testing effectiveness (Phase 2)UnknownNCT00287924
What this trial is testing

High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Cancer and Leukaemia Group 29
Testing effectiveness (Phase 2)Study completedNCT00285389
What this trial is testing

Treatment of Mantle Cell Lymphoma at Diagnosis for Patients Under 65 Years

Who this might be right for
Mantle Cell Lymphoma
French Innovative Leukemia Organisation 39
Testing effectiveness (Phase 2)Study completedNCT00477750
What this trial is testing

Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 33
Not applicableLooking for participantsNCT06202118
What this trial is testing

Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.

Who this might be right for
Breast CancerRecurrent Breast CancerBreast Carcinoma
Alpha Tau Medical LTD. 10
Not applicableStudy completedNCT05488613
What this trial is testing

Healthcare Resource Utilization in Adults Diagnosed With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)
Novartis Pharmaceuticals 81
Not applicableStudy completedNCT02250755
What this trial is testing

MRI Perfusion on T1 and T2 Brain Lesion(s)

Who this might be right for
Lung Carcinoma Metastatic to the Brain
University Hospital, Lille 30
Testing effectiveness (Phase 2)Study completedNCT01062425
What this trial is testing

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Adult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 261
Testing effectiveness (Phase 2)Study completedNCT00724568
What this trial is testing

Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Michigan Rogel Cancer Center 74
Early research (Phase 1)Study completedNCT00742924
What this trial is testing

Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

Who this might be right for
Sarcoma
Children's Oncology Group 24
Testing effectiveness (Phase 2)Ended earlyNCT03927222
What this trial is testing

Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma

Who this might be right for
Glioblastoma
Mustafa Khasraw, MBChB, MD, FRCP, FRACP 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT04635189
What this trial is testing

Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Rochester 28
Very early researchLooking for participantsNCT05423210
What this trial is testing

Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Stony Brook University 12
Testing effectiveness (Phase 2)Looking for participantsNCT07159620
What this trial is testing

Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients

Who this might be right for
Adult T-cell Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University 27
Early research (Phase 1)Study completedNCT02326584
What this trial is testing

A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AML

Who this might be right for
Acute Myeloid LeukemiaAcute Myelogenous Leukemia
Seagen Inc. 116
Testing effectiveness (Phase 2)Study completedNCT04840238
What this trial is testing

30000 IU Per Week Vitamin D Treatment in PCOS Patients

Who this might be right for
Polycystic Ovary SyndromeVitamin D Deficiency
Semmelweis University 115
Next Page